Endoscopic Band Ligation Versus Argon Plasma Coagulation in the Treatment of Gastric Antral Vascular Ectasia : A Systematic Review and Meta-Analysis of Randomized Controlled Trials
BACKGROUND/AIMS: Argon plasma coagulation (APC) is the most commonly used endoscopic treatment for gastric antral vascular ectasia (GAVE). Endoscopic band ligation (EBL) has emerged as an alternative therapy. Our goal was to evaluate the feasibility, efficacy, and safety of APC and EBL for the treatment of GAVE. This is the first systematic review that included only randomized controlled trials (RCTs) on this topic.
METHODS: A comprehensive search was performed using electronic databases to identify RCTs comparing APC and EBL for the treatment of GAVE following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.
RESULTS: Four RCTs were included, with a total of 204 patients. EBL was related to higher endoscopic eradication rates risk difference [RD], 0.29; 95% confidence interval [CI] [0.14, 0.44]; I2=0%) and less bleeding recurrence than APC (RD, 0.29; 95% CI [0.15, 0.44]; I2=0%). Patients treated with EBL required fewer blood transfusions (mean difference [MD], 1.49; 95% CI [0.28, 2.71]; I2=96%) and hospitalizations (MD, 0.29; 95% CI [0.19, 0.39]; I2=0%). The number of sessions required for the obliteration of lesions was higher with APC. There was no difference in the incidence of adverse events.
CONCLUSION: EBL is superior to APC in the treatment of GAVE in terms of endoscopic eradication rates, recurrence of bleeding, and transfusion requirements.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Clinical endoscopy - 54(2021), 5 vom: 01. Sept., Seite 669-677 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hirsch, Bruno Salomão [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Argon plasma coagulation |
|---|
| Anmerkungen: |
Date Revised 22.10.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5946/ce.2021.063 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326018662 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326018662 | ||
| 003 | DE-627 | ||
| 005 | 20231225193701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5946/ce.2021.063 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1086.xml |
| 035 | |a (DE-627)NLM326018662 | ||
| 035 | |a (NLM)34053215 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hirsch, Bruno Salomão |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endoscopic Band Ligation Versus Argon Plasma Coagulation in the Treatment of Gastric Antral Vascular Ectasia |b A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a BACKGROUND/AIMS: Argon plasma coagulation (APC) is the most commonly used endoscopic treatment for gastric antral vascular ectasia (GAVE). Endoscopic band ligation (EBL) has emerged as an alternative therapy. Our goal was to evaluate the feasibility, efficacy, and safety of APC and EBL for the treatment of GAVE. This is the first systematic review that included only randomized controlled trials (RCTs) on this topic | ||
| 520 | |a METHODS: A comprehensive search was performed using electronic databases to identify RCTs comparing APC and EBL for the treatment of GAVE following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines | ||
| 520 | |a RESULTS: Four RCTs were included, with a total of 204 patients. EBL was related to higher endoscopic eradication rates risk difference [RD], 0.29; 95% confidence interval [CI] [0.14, 0.44]; I2=0%) and less bleeding recurrence than APC (RD, 0.29; 95% CI [0.15, 0.44]; I2=0%). Patients treated with EBL required fewer blood transfusions (mean difference [MD], 1.49; 95% CI [0.28, 2.71]; I2=96%) and hospitalizations (MD, 0.29; 95% CI [0.19, 0.39]; I2=0%). The number of sessions required for the obliteration of lesions was higher with APC. There was no difference in the incidence of adverse events | ||
| 520 | |a CONCLUSION: EBL is superior to APC in the treatment of GAVE in terms of endoscopic eradication rates, recurrence of bleeding, and transfusion requirements | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Argon plasma coagulation | |
| 650 | 4 | |a Endoscopic band ligation | |
| 650 | 4 | |a Endoscopy | |
| 650 | 4 | |a Gastric antral vascular ectasia | |
| 700 | 1 | |a Ribeiro, Igor Braga |e verfasserin |4 aut | |
| 700 | 1 | |a Funari, Mateus Pereira |e verfasserin |4 aut | |
| 700 | 1 | |a de Moura, Diogo Turiani Hourneaux |e verfasserin |4 aut | |
| 700 | 1 | |a Matuguma, Sergio Eiji |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Luna, Sergio A |e verfasserin |4 aut | |
| 700 | 1 | |a Mancini, Fabio Catache |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira, Guilherme Henrique Peixoto |e verfasserin |4 aut | |
| 700 | 1 | |a Bernardo, Wanderley Marques |e verfasserin |4 aut | |
| 700 | 1 | |a de Moura, Eduardo Guimarães Hourneaux |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical endoscopy |d 2011 |g 54(2021), 5 vom: 01. Sept., Seite 669-677 |w (DE-627)NLM218997000 |x 2234-2400 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2021 |g number:5 |g day:01 |g month:09 |g pages:669-677 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5946/ce.2021.063 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2021 |e 5 |b 01 |c 09 |h 669-677 | ||